Allelic variants in the zinc transporter-3 gene, SLC30A3, a candidate gene identified from gene expression studies, show gender-specific association with schizophrenia

European Psychiatry

Volumn 29, Issue 3, 2014, Pages 172-178

  Perez Becerril, C ^a   Morris, A G ^a   Mortimer, A ^b   McKenna, P J ^c   de Belleroche, J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c Benito Menni Complex Assistencial en Salut Mental   (Spain)

Author keywords

Candidate gene associations; Gender effects in schizophrenia; Schizophrenia; SLC30A3; Synaptic plasticity; Zinc transporter 3 (ZNT3)

Indexed keywords

UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 3; CATION TRANSPORT PROTEIN; SLC30A3 PROTEIN, HUMAN;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; ALLELE; CASE CONTROL STUDY; GENETICS; SEX DIFFERENCE;

ALLELES; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; COHORT STUDIES; ENGLAND; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SEX FACTORS;

EID: 84896690645     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2013.05.007     Document Type: Article

References (35)

1. Adlard P.A., Parncutt J.M., Finkelstein D.I., Bush A.I. Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory deficits of Alzheimer's disease?. J Neurosci 2010, 30:1631-1636.
2. Amos W., Driscoll E., Hoffman J.I. Candidate genes versus genome-wide associations: which are better for detecting genetic susceptibility to infectious disease?. Proc R Soc B Biol Sci 2011, 278:1183-1188.
3. Angermeyer M.C., Kuhn L. Gender differences in age at onset of schizophrenia. An overview. Eur Arch Psychiatry Neurol Sci 1988, 237:351-364.
4. Barnes M.R., Huxley-Jones J., Maycox P.R., Lennon M., Thornber A., Kelly F., et al. Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia. J Neurosci Res 2011, 89:1218-1227.
5. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
6. Begemann M.J., Dekker C.F., van Lunenburg M., Sommer I.E. Estrogen augmentation in schizophrenia: a quantitative review of current evidence. Schizophr Res 2012, 141:179-184.
7. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995, 57:289-300.
8. Benjamini Y., Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat 2001, 29:1165-1188.
9. Chissoe S, Ehm M, St. Jean P. Genes associated with schizophrenia. Patent Publication No. US 2008/0176239 A1:1-49.
10. Clarke G.M., Anderson C.A., Pettersson F.H., Cardon L.R., Morris A.P., Zondervan K.T. Basic statistical analysis in genetic case-control studies. Nat Protoc 2011, 6:121-133.
11. Faul F., Erdfelder E., Lang A.G., Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39:175-191.
12. Hafner H., Maurer K., Loffler W., Riecher-Rossler A. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 1993, 162:80-86.
13. Hanley J.A. A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health 2001, 55:508-514.
14. International Schizophrenia Consortium, Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
15. Izumi Y., Auberson Y.P., Zorumski C.F. Zinc modulates bidirectional hippocampal plasticity by effects on NMDA receptors. J Neurosci 2006, 26:7181-7188.
16. Kim B., Kim H., Joo Y.H., Lim J., Kim C.Y., Song K. Sex-different association of DAO with schizophrenia in Koreans. Psychiatry Res 2010, 179:121-125.
17. Lee J.Y., Kim J.H., Hong S.H., Lee J.Y., Cherny R.A., Bush A.I., et al. Estrogen decreases zinc transporter3 expression and synaptic vesicle zinc levels in mouse brain. J Biol Chem 2004, 279:8602-8607.
18. Martel G., Hevi C., Friebely O., Baybutt T., Shumyatsky G.P. Zinc transporter 3 is involved in learned fear and extinction, but not in innate fear. Learn Mem 2010, 17:582-590.
19. Maycox P.R., Kelly F., Taylor A., Bates S., Reid J., Logendra R., et al. Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry 2009, 14:1083-1094.
20. Mortimer A.M., McKenna P.J., Lund C.E., Mannuzza S. Rating of negative symptoms using the High Royds Evaluation of Negativity (HEN) score. Br J Psychiatry 1989, Suppl.7:89-92.
21. Palmiter R.D., Cole T.B., Quaife C.J., Findley S.D. ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc Natl Acad Sci USA 1996, 93:14934-14939.
22. Pan E., Zhang X.A., Huang Z., Krezel A., Zhao M., Tinberg C.E., et al. Vesicular zinc promotes presynaptic and inhibits postsynaptic long-term potentiation of mossy fiber-CA3 synapse. Neuron 2011, 71:1116-1126.
23. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A.R., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575.
24. Qian J., Noebels J.L. Visualization of transmitter release with zinc fluorescence detection at the mouse hippocampal mossy fibre synapse. J Physiol 2005, 566:747-758.
25. Ram Murthy A., Purushottam M., Kiran Kumar H.B., Vallikiran M., Krishna N., Jayramu Sriharsha K., et al. Gender-specific association of TSNAX/DISC1 locus for schizophrenia and bipolar affective disorder in South Indian population. J Hum Genet 2012, e:1-8.
26. Ripke S., Sanders A.R., Kendler K.S., Levinson D.F., Sklar P., Holmans P.A., et al. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011, 43:964-976.
27. Salazar G., Craige B., Love R., Kalman D., Faundez V. Vglut1 and ZnT3 co-targeting mechanisms regulate vesicular zinc stores in PC12 cells. J Cell Sci 2005, 118:1911-1921.
28. Sensi S.L., Paoletti P., Bush A.I., Sekler I. Zinc in the physiology and pathology of the CNS. Nat Rev Neurosci 2009, 10:780-791.
29. Sham P.C., Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995, 59:97-105.
30. Shifman S., Johannesson M., Bronstein M., Chen S.X., Collier D.A., Craddock N.J., et al. Genome-wide association identifies a common variant in the reline gene that increases the risk of schizophrenia only in women. PLoS Genet 2008, 4. e28 001-007.
31. Sindreu C., Palmiter R.D., Storm D.R. Zinc transporter ZnT-3 regulates presynaptic Erk 1/2 signalling and hippocampus-dependent memory. Proc Natl Acad Sci USA 2011, 108:3366-3370.
32. Sindreu C.B., Varoqui H., Erickson J.D., Pérez-Clausell J. Boutons containing vesicular zinc define a subpopulation of synapses with low AMPAR content in rat hippocampus. Cereb Cortex 2003, 13:823-829.
33. Wenzel H.J., Cole T.B., Born D.E., Schwartzkroin P.A., Palmiter R.D. Ultrastructural localization of zinc transporter-3 (ZnT-3) to synaptic vesicle membranes within mossy fiber boutons in the hippocampus of mouse and monkey. Proc Natl Acad Sci USA 1997, 94:12676-12681.
34. Williams H.J., Norton N., Dwyer S., Moskvina V., Nikolov I., Carroll L. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry 2011, 16:429-441.
35. Zhang F., Chen Q., Ye T., Lipska B.K., Straub R.E., Vakkalanka R., et al. Evidence of sex-modulated association of ZNF804A with schizophrenia. Biol Psychiatry 2011, 69:914-917.